Answers are grounded in this paper and cite their sources.
T cells and decreasing regulatory T cells in the tumor while increasing effector memory T cells in the spleen. Overall, our platform demonstrates that CCMP@R837 can be a potential candidate for preventive cancer vaccines in the clinic.
No takes yet. Share an insight, caveat, or question.
Xiao et al. (2021) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: